Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Prenetics

Prenetics
2014 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
Series B LATEST DEAL TYPE
$40M LATEST DEAL AMOUNT
14 INVESTORS
Description

Developer of a pharmacogenomics platform designed to offer personalized, predictive and preventive treatments. The company's pharmacogenomics platform offers a health-coaching application that provides individuals with a DNA profile in order to facilitate optimal diet, fitness and response to drugs and enables them to understand their genetic risk of common health conditions such as Type 2 Diabetes, High Blood Pressure and High Cholesterol, enabling physicians to help patients identify the right drug, right dosage and to list out potential adverse drug effects (ADEs), based on one's genetic profile platform.

Formerly Known As
Multigene
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • 7/F, Prosperity Millennia Plaza
  • 663 King's Road
  • Quarry Bay
  • Hong Kong

+852 2210 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Prenetics’s full profile, request a free trial.

Prenetics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 18-Oct-2017 $40M 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 16-Mar-2016 0000 000.00 Completed Startup
2. Later Stage VC 01-Nov-2015 $2.65M Completed Startup
1. Seed Round 03-Dec-2014 $2.65M $2.65M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Prenetics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomic Expression Venture Capital-Backed New York, NY 0 00000 0000000000 00000
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 00000 000000&0 00000
0000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
0000000000 Private Equity-Backed Princeton, NJ 0000 000.00 000000000000 000.00
000000000 00000000 Venture Capital-Backed Helsinki, Finland 000 000.00 00000 00000
To view this company’s complete list of competitors, request access »

Prenetics Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000 29-Jan-2019 000000000000000000 Application Software 000 0000000
00000000 00000000 08-Nov-2018 00000 0000000 Biotechnology 00000 00000
DNAFit Life Sciences 17-Apr-2018 Merger/Acquisition 0000 Biotechnology 00000 00000
To view this company’s complete investment and acquisition history, request access »

Prenetics Subsidiaries (2)

Company Name Industry Location Founded
DNAFit Life Sciences Biotechnology London, United Kingdom 2013
0000 000000000 Application Software London, United Kingdom 0000
To view this company’s complete subsidiary history, request access »

Prenetics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alibaba Entrepreneurs Fund Corporate Venture Capital Minority 000 0000 000000 0
Beyond Ventures Venture Capital Minority 000 0000 000000 0
eGarden Ventures Venture Capital Minority 000 0000 000000 0
MFund Venture Capital Minority 000 0000 000000 0
Yuantai Investment Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Prenetics Executive Team (11)

Name Title Board
Seat
Contact
Info
Danny Yeung Chief Executive Officer & Co-Founder
Peter Wong Chief Technology Officer
Lawrence Tzang Ph.D Co-Founder & Chief Scientific Officer
Michael Yang Ph.D Co-Founder & Member of Chief Scientific Board
Senthil Sundaram MD Chief Clinical Officer
You’re viewing 5 of 11 executives. Get the full list »